全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

复元活血汤治疗III型前列腺炎的网络药理学研究
Network Pharmacology of Fuyuan Huoxue Tang in the Treatment of Type III Prostatitis

DOI: 10.12677/PI.2023.122016, PP. 121-130

Keywords: 复元活血汤,III型前列腺炎,网络药理学
Fuyuan Huoxue Tang
, Type III Prostatitis, Network Pharmacology

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:通过网络药理学方法探讨复元活血汤治疗III型前列腺炎的作用机制。方法:使用中药系统药理学分析平台(TCMSP)获取复元活血汤的活性成分及药物靶点,从GeneCards、DisGeNET、OMIM、Drugbank数据库中筛选III型前列腺炎的疾病靶点,并与复元活血汤的药物靶点相映射取交集。通过STRING数据库和Cytoscape3.9.1软件构建中药–活性成分–靶点网络及PPI网络,并分析网络中的活性成分与关键靶点。利用R语言相关程序包进行GO功能、KEGG通路富集分析。结果:复元活血汤含有183种活性成分,对应的药物靶点有242个。复元活血汤治疗III型前列腺炎的潜在靶点有123个;主要活性成分有槲皮素、木犀草素、山奈酚、柚皮素等;关键靶点有丝裂原活化蛋白激酶14 (MAPK14)、转录因子p65 (RELA)、信号转导和转录激活因子3 (STAT3)等。GO功能富集分析涉及1757个生物过程、154个细胞组和98个分子功能;KEGG通路富集分析涉及192条信号通路。结论:复元活血汤可通过多种中药成分和多个靶点影响肿瘤坏死因子(TNF)、核因子κ B (NF-κ B)、toll样受体、丝裂原活化蛋白激酶(MAPK)等信号通路,治疗III型前列腺炎。
Objective: To investigate the mechanism of action of Fuyuan Huoxue Tang in the treatment of type III prostatitis through a network pharmacology approach. Methods: The active ingredients and drug targets of Fuyuan Huoxue Tang were obtained using the Traditional Chinese Medicine Systematic Pharmacology Analysis Platform (TCMSP), and the disease targets of type III prostatitis were screened from the GeneCards, DisGeNET, OMIM, and Drugbank databases and mapped to the drug targets of Fuyuan Huoxue Tang to obtain the intersection. Construct TCM-active ingredient-target network and PPI network by STRING database and Cytoscape 3.9.1 software, and analyze the active ingredients and key targets in the network. Use the R language-related program package for GO function, analysis by KEGG pathway enrichment. Results: Fuyuan Huoxue Tang has sub 183 active ingredients and 242 corresponding drug targets. There were 123 potential targets of Fuyuan Hu-oxue Tang for the treatment of type III prostatitis; the main active ingredients were quercetin, lig-nocaine, kaempferol, naringenin, etc.; the key targets were MAPK14, RELA, STAT3, etc. The GO function enrichment analysis involved 1757 biological processes, 154 cell groups and 98 molecular functions; the KEGG pathway enrichment analysis involved 192 signaling KEGG pathway enrich-ment analysis involved 192 signaling pathways. Conclusion: Fuyuan Huoxue Tang may be used to treat type III prostatitis by affecting TNF, NF-κ B, Toll-like receptors, MAPK and other signaling pathways through multiple herbal components and multiple targets.

References

[1]  Khan, F.U., Ihsan, A.U., Khan, H.U., et al. (2017) Comprehensive Overview of Prostatitis. Biomedicine & Pharma-cotherapy, 94, 1064-1076.
https://doi.org/10.1016/j.biopha.2017.08.016
[2]  Brünahl, C., Dybowski, C., Albrecht, R., et al. (2017) Mental Disorders in Patients with Chronic Pelvic Pain Syndrome (CPPS). Journal of Psychosomatic Research, 98, 19-26.
https://doi.org/10.1016/j.jpsychores.2017.04.011
[3]  Dybowski, C., L?we, B. and Brünahl, C. (2018) Predictors of Pain, Urinary Symptoms and Quality of Life in Patients with Chronic Pelvic Pain Syndrome (CPPS): A Prospective 12-Month Follow-Up Study. Journal of Psychosomatic Research, 112, 99-106.
https://doi.org/10.1016/j.jpsychores.2018.06.013
[4]  商学军. 慢性前列腺炎/慢性盆腔疼痛综合征诊疗指南[J]. 中华男科学杂志, 2022, 28(6): 544-559.
[5]  赵呈昀, 安瑞华. 慢性前列腺炎/慢性盆腔疼痛综合征治疗进展[J]. 中国男科学杂志, 2021, 35(1): 55-59.
[6]  王继光, 林金秀, 陈鲁原, 等. α受体阻滞剂降压治疗中国专家共识[J]. 中华高血压杂志, 2022, 30(5): 409-416.
[7]  郭海翔, 石鑫, 李炯明, 等. 锯叶棕果实提取物治疗BPH的疗效及安全性评价[J]. 昆明医科大学学报, 2018, 39(11): 16-19.
[8]  Franco, J.V., Turk, T., Jung, J.H., et al. (2020) Phar-macological Interventions for Treating Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Cochrane Systematic Re-view. BJU International, 125, 490-496.
https://doi.org/10.1111/bju.14988
[9]  俞旭君, 高庆和. 慢性前列腺炎中西医结合多学科诊疗指南[J]. 中华男科学杂志, 2020, 26(4): 369-376.
[10]  李兰群, 李海松, 郭军, 等. 慢性前列腺炎中医证型临床调查[J]. 中华中医药杂志, 2011, 26(3): 451-454.
[11]  谢作钢, 陈盛镱, 徐潘, 等. 复元活血汤对慢性非细菌性前列腺炎前列腺液细胞因子的影响[J]. 浙江中医杂志, 2018, 53(6): 397-398.
[12]  申军, 常青, 吴栖岸, 等. 复元活血汤联合坦索罗辛治疗气滞血瘀型慢性前列腺炎疗效及对IL-8、TNF-α影响的研究[J]. 中国地方病防治杂志, 2018, 33(1): 57-58.
[13]  彭期兵, 吴小林. 复元活血汤加减治疗慢性前列腺炎气滞血瘀证疗效观察[J]. 现代中西医结合杂志, 2017, 26(12): 1319-1321.
[14]  Pontari, M.A. and Ruggieri, M.R. (2008) Mechanisms in Prostatitis/Chronic Pelvic Pain Syndrome. The Journal of Urology, 179, 61-67.
https://doi.org/10.1016/j.juro.2008.03.139
[15]  钟树志, 裴东, 晁杲, 等. 复元活血汤对大鼠损伤坐骨神经组织p-Src、p-Erk表达的影响[J]. 中国临床药理学与治疗学, 2017, 22(7): 731-737.
[16]  许大勇. 复元活血汤对脊柱骨折患者术后炎性因子、凝血功能及疼痛程度的影响[J]. 中药药理与临床, 2015, 31(3): 140-142.
[17]  祁建宏, 董芳旭. 黄酮类化合物药理作用研究进展[J]. 北京联合大学学报, 2020, 34(3): 89-92.
[18]  赵明, 金珊. 槲皮素对III型慢性前列腺炎/骨盆疼痛综合征模型大鼠作用及其机制研究[J]. 临床泌尿外科杂志, 2019, 34(7): 545-548.
[19]  Meng, L.Q., Yang, F.Y., Wang, M.S., et al. (2018) Quercetin Protects against Chronic Prostatitis in Rat Model through NF-κB and MAPK Signaling Pathways. The Prostate, 78, 790-800.
https://doi.org/10.1002/pros.23536
[20]  吕畅, 王红芳, 阎雪莹. 木犀草素抗氧化作用研究进展[J]. 黑龙江医药, 2015, 28(5): 1019-1022.
[21]  Ashaari, Z., Hadjzadeh, M.A., Hassanzadeh, G., et al. (2018) The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review. Journal of Molecular Neuroscience, 65, 491-506.
https://doi.org/10.1007/s12031-018-1094-2
[22]  Madkour, M.M., Anbar, H.S. and El-Gamal, M.I. (2021) Current Status and Future Prospects of p38α/MAPK14 Kinase and Its Inhibitors. European Journal of Medicinal Chemistry, 213, Article ID: 113216.
https://doi.org/10.1016/j.ejmech.2021.113216
[23]  程丽艳, 屠凌岚, 史红. p38MAPK对慢性前列腺炎疼痛的影响及槲皮素的干预作用[J]. 中国现代应用药学, 2016, 33(8): 984-988.
[24]  李文峰, 顾豫飞. NLRP3/NF-κB通路在慢性前列腺炎的变化和意义[J]. 中南医学科学杂志, 2019, 47(2): 146-148.
[25]  艾依热提?买买提, 木拉提?热夏提. 龙胆苦苷对慢性前列腺炎的作用及对NF-κB和MAPKs信号通路活化的研究[J]. 实用药物与临床, 2021, 24(2): 111-115.
[26]  赵亮, 陈玉琴, 程邵龙, 等. 姜黄素对免疫性前列腺炎大鼠肿瘤坏死因子-α、核因子-κB、环氧合酶-2表达的影响[J]. 重庆医科大学学报, 2016, 41(9): 910-914.
[27]  Hillmer, E.J., Zhang, H., Li, H.S., et al. (2016) STAT3 Signaling in Immunity. Cytokine & Growth Factor Reviews, 31, 11-15.
https://doi.org/10.1016/j.cytogfr.2016.05.001
[28]  李承宗. RIP1与TNF-α诱导信号通路关系的研究进展[J]. 中国卫生标准管理, 2019, 10(19): 66-69.
[29]  Li, Q.Y., Xu, H.Y. and Yang, H.J. (2017) Effect of Proinflammatory Factors TNF-α, IL-1β, IL-6 on Neuropathic Pain. China Journal of Chinese Materia Medica, 42, 3709-3712.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133